Exploratory development and internal validation of a preoperative laboratory-based nomogram for perineural invasion in distal cholangiocarcinoma

Background Perineural invasion (PNI) is common in distal cholangiocarcinoma (dCCA), but its preoperative assessment remains challenging. We conducted an exploratory study to develop and internally validate a laboratory-based model for estimating PNI probability, recognizing the limitations imposed by the small number of PNI-negative patients. Methods Patients with conventional dCCA who underwent curative-intent resection at Beijing Chao-Yang Hospital between January 2011 and June 2025 were retrospectively included. Routine preoperative laboratory variables were assessed using Elastic Net regression with 500 bootstrap resamples for stability selection, followed by multivariable Firth penalized logistic regression. Discrimination, calibration, and overall prediction error were examined. Bootstrap internal validation repeated preprocessing, predictor selection at the chosen 70% stability threshold, and model fitting; it did not incorporate the original data-informed comparison and choice of stability thresholds. Results Among 233 patients, 206 (88.4%) had PNI and 27 (11.6%) did not. Five predictors were retained: fibrinogen, mean platelet volume (MPV), mean corpuscular hemoglobin concentration (MCHC), log(CEA + 1), and log(CA19-9 + 1). MPV was associated with PNI (OR, 1.565; 95% CI, 1.072–2.382; P = 0.019). The apparent AUC was 0.748. After bootstrap optimism correction conditional on the selected 70% threshold, the AUC was 0.718 (95% CI, 0.662–0.781), Brier score 0.098 (95% CI, 0.081–0.129), calibration intercept 0.185 (95% CI, −0.101 to 0.429), and calibration slope 0.871 (95% CI, 0.542–1.405). The prevalence-only model had a Brier score of 0.103. The formal sample-size assessment indicated a substantial shortfall relative to the evaluated development requirements. Conclusions This exploratory five-variable laboratory model showed modest incremental predictive information beyond PNI prevalence. Only 27 patients were PNI-negative, and the cohort was substantially smaller than the estimated sample size required for stable model development. The current results should not be used to guide treatment or surveillance decisions and require evaluation in substantially larger, independent cohorts.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-12
DOI
https://doi.org/10.3389/fmed.2026.1970156
Primary Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exploratory development and internal validation of a preoperative laboratory-based nomogram for perineural invasion in distal cholangiocarcinoma

Xiao-Yong Ye, Zhili Ji, Kexin Wang, Hezhi Wang et al.
Frontiers in Medicine
Cholangiocarcinoma and Gallbladder Cancer Studies
article

Exploratory development and internal validation of a preoperative laboratory-based nomogram for perineural invasion in distal cholangiocarcinoma

Xiao-Yong Ye, Zhili Ji, Kexin Wang, Hezhi Wang, Qiang He
article en

Abstract

Background Perineural invasion (PNI) is common in distal cholangiocarcinoma (dCCA), but its preoperative assessment remains challenging. We conducted an exploratory study to develop and internally validate a laboratory-based model for estimating PNI probability, recognizing the limitations imposed by the small number of PNI-negative patients. Methods Patients with conventional dCCA who underwent curative-intent resection at Beijing Chao-Yang Hospital between January 2011 and June 2025 were retrospectively included. Routine preoperative laboratory variables were assessed using Elastic Net regression with 500 bootstrap resamples for stability selection, followed by multivariable Firth penalized logistic regression. Discrimination, calibration, and overall prediction error were examined. Bootstrap internal validation repeated preprocessing, predictor selection at the chosen 70% stability threshold, and model fitting; it did not incorporate the original data-informed comparison and choice of stability thresholds. Results Among 233 patients, 206 (88.4%) had PNI and 27 (11.6%) did not. Five predictors were retained: fibrinogen, mean platelet volume (MPV), mean corpuscular hemoglobin concentration (MCHC), log(CEA + 1), and log(CA19-9 + 1). MPV was associated with PNI (OR, 1.565; 95% CI, 1.072–2.382; P = 0.019). The apparent AUC was 0.748. After bootstrap optimism correction conditional on the selected 70% threshold, the AUC was 0.718 (95% CI, 0.662–0.781), Brier score 0.098 (95% CI, 0.081–0.129), calibration intercept 0.185 (95% CI, −0.101 to 0.429), and calibration slope 0.871 (95% CI, 0.542–1.405). The prevalence-only model had a Brier score of 0.103. The formal sample-size assessment indicated a substantial shortfall relative to the evaluated development requirements. Conclusions This exploratory five-variable laboratory model showed modest incremental predictive information beyond PNI prevalence. Only 27 patients were PNI-negative, and the cohort was substantially smaller than the estimated sample size required for stable model development. The current results should not be used to guide treatment or surveillance decisions and require evaluation in substantially larger, independent cohorts.

Frontiers in MedicineVol. 13
Capital Medical University (CN), Beijing Chao-Yang Hospital, Capital Medical University (CN)
Good health and well-being
Cholangiocarcinoma and Gallbladder Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon